Literature DB >> 30854326

Concomitant use of Impella while on peripheral veno-arterial extracorporeal membrane oxygenation: de-escalate and ambulate.

Letizia Fausta Bertoldi1, Luca Bertoglio2, Federico Pappalardo3.   

Abstract

Year:  2019        PMID： 30854326      PMCID： PMC6379192          DOI： 10.21037/acs.2018.10.15

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  5 in total

Review 1.  Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock.

Authors:  Mary E Keebler; Elias V Haddad; Chun W Choi; Stuart McGrane; Sandip Zalawadiya; Kelly H Schlendorf; D Marshall Brinkley; Matthew R Danter; Mark Wigger; Jonathan N Menachem; Ashish Shah; JoAnn Lindenfeld
Journal:  JACC Heart Fail       Date:  2018-04-11       Impact factor: 12.035

2.  Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.

Authors:  Federico Pappalardo; Christian Schulte; Marina Pieri; Benedikt Schrage; Rachele Contri; Gerold Soeffker; Teresa Greco; Rosalba Lembo; Kai Müllerleile; Antonio Colombo; Karsten Sydow; Michele De Bonis; Florian Wagner; Hermann Reichenspurner; Stefan Blankenberg; Alberto Zangrillo; Dirk Westermann
Journal:  Eur J Heart Fail       Date:  2016-10-06       Impact factor: 15.534

3.  National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis.

Authors:  Robert Stretch; Christopher M Sauer; David D Yuh; Pramod Bonde
Journal:  J Am Coll Cardiol       Date:  2014-10-07       Impact factor: 24.094

4.  Using the Minimally Invasive Impella 5.0 via the Right Subclavian Artery Cutdown for Acute on Chronic Decompensated Heart Failure as a Bridge to Decision.

Authors:  Aditya Bansal; Jay K Bhama; Rajan Patel; Sapna Desai; Stacy A Mandras; Hamang Patel; Tyrone Collins; John P Reilly; Hector O Ventura; P Eugene Parrino
Journal:  Ochsner J       Date:  2016

5.  Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival.

Authors:  Michele L Esposito; Janelle Jablonski; Allison Kras; Sara Krasney; Navin K Kapur
Journal:  Int J Artif Organs       Date:  2018-02-20       Impact factor: 1.595
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.